OBJECTIVES: Object of this work is to evaluate activity and tolerance of @entity12698 in out- @entity1 's department practice. @entity1 AND METHODS: In this study we enlisted 46 @entity1 , affected by @entity158 of inflammatory or degenerative origin; any of them ever did continued therapy with NSAIDs before. We administered 200 mg daily dose of @entity12698 for at least three months. Each @entity1 has been evaluated by the Visual Analogic Score (VAS) Scale before and after the therapy. RESULTS: The data We obtained agree with those of multicenter studies like CLASS. @entity12698 had similar efficacy respect with traditional NSAIDs, with good control of @entity158 in both @entity571 and @entity158 (p < 0.000). Not good results were obtained for control of acute-onset @entity158 . In our population We didn't find side-effects different from those included in the technical-form of the drug. The only @entity1 who complained of @entity158 did not stop the treatment, because the symptom resolved with assumption of the drug during meals. CONCLUSIONS: By the analysis of the results We consider @entity12698 useful for the control of @entity158 in the treatment of @entity571 and @entity792 like @entity309 . Anyway, treatment with @entity12698 (as with all Coxib-family drugs) should be reserved for long-lasting treatments in @entity1 at risk for @entity360 .

[Effectiveness and tolerability of XXXX in outpatient department practice].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity12698 :: ('MESH:C105934', 'Chemical') :: ['Celecoxib'] @entity360 :: ('MESH:D006471', 'Disease') :: ['gastrointestinal bleeding'] @entity571 :: ('MESH:D010003', 'Disease') :: ['osteoarthrosis', 'osteoarthrosic'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain', 'epigastric pain', 'arthritic pain'] @entity792 :: ('MESH:D001327', 'Disease') :: ['autoimmune diseases'] @entity309 :: ('MESH:D001172', 'Disease') :: ['Rheumatoid Arthritis']
@entity12698 :: (MESH:C105934,Chemical) :: ['celecoxib']
